Stocks LONN
SWXLonza Group AG (LONN)
We have not processed filings for Lonza Group AG yet. This page fills in on its own once we have read them.
What Lonza Group AG does
Lonza Group provides contract development and manufacturing services to the pharmaceutical, biotechnology, and nutrition industries. It manufactures active pharmaceutical ingredients, biologics, cell and gene therapies, and capsules for drug developers and healthcare companies that outsource their product development and production operations. Its shares trade on SWX under the ticker LONN.
Earnings: every quarter and the next report date
Latest SEC filings
Questions about LONN
What does Lonza Group AG do?
Lonza Group provides contract development and manufacturing services to the pharmaceutical, biotechnology, and nutrition industries. It manufactures active pharmaceutical ingredients, biologics, cell and gene therapies, and capsules for drug developers and healthcare companies that outsource their product development and production operations. Its shares trade on SWX under the ticker LONN.
Theses that mention LONN
Follow LONN
Get an email when Lonza Group AG files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Lonza Group AG tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.